Kyongbo Pharmaceutical Co Ltd Cash Flow Reinvestment Rate

Latest as of March 2026: 11.05x

Kyongbo Pharmaceutical Co Ltd cash flow reinvestment rate. Kyongbo Pharmaceutical Co Ltd (214390) has a Cash Flow Reinvestment Rate of 11.05x as of March 2026, reinvesting ₩19.76 Billion (capex ₩15.55 Billion plus investments ₩-4.21 Billion) from operating cash flow of ₩1.79 Billion. Explore 214390 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

11.05x
(Capex + Investments) / Operating CF

Total Reinvested

₩19.76 Billion
Capex + Investments

Operating Cash Flow

₩1.79 Billion
KRW

Capital Expenditures

₩15.55 Billion
KRW

Cash Flow Reinvestment Rate of Kyongbo Pharmaceutical Co Ltd (2014–2025)

Cash flow reinvestment rate of Kyongbo Pharmaceutical Co Ltd from 2014 to 2025. Historical reinvestment intensity for Kyongbo Pharmaceutical Co Ltd across 11 annual periods. Explore Kyongbo Pharmaceutical Co Ltd capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Kyongbo Pharmaceutical Co Ltd Cash Flow Reinvestment Rate by Year (2014–2025)

Kyongbo Pharmaceutical Co Ltd cash flow reinvestment rate by year from 2014 to 2025. Year-by-year capital reinvestment analysis for Kyongbo Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see how efficiently does Kyongbo Pharmaceutical Co Ltd generate cash.

Year Reinvestment Rate Total Reinvested (KRW) Operating CF Capex YoY Change
2025 5.74x ₩42.82 Billion ₩7.46 Billion ₩41.61 Billion ▼ -94.0%
2024 95.93x ₩14.31 Billion ₩149.12 Million ₩13.18 Billion ▲ +3205.3%
2023 2.90x ₩14.06 Billion ₩4.84 Billion ₩10.88 Billion ▲ +4.7%
2022 2.77x ₩28.06 Billion ₩10.13 Billion ₩13.18 Billion ▲ +143.5%
2021 1.14x ₩20.45 Billion ₩17.97 Billion ₩18.32 Billion ▲ +20.5%
2020 0.94x ₩19.63 Billion ₩20.80 Billion ₩12.44 Billion ▼ -18.6%
2019 1.16x ₩27.45 Billion ₩23.67 Billion ₩23.25 Billion ▲ +256.4%
2017 0.33x ₩8.40 Billion ₩25.81 Billion ₩7.40 Billion ▼ -79.3%
2016 1.57x ₩39.84 Billion ₩25.33 Billion ₩19.68 Billion ▼ -76.0%
2015 6.56x ₩27.80 Billion ₩4.24 Billion ₩27.26 Billion ▲ +423.9%
2014 1.25x ₩20.08 Billion ₩16.04 Billion ₩19.28 Billion —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow